Skip to main content
. 2020 Sep 11;12(10):e12013. doi: 10.15252/emmm.202012013

Table 1.

Comparative FACS analysis of subject‐derived ALX1 165F/165F and control NCC at passages 1 and 4

Passage 1 Passage 4
Control (ALX1 165L/165L) ALX1 165F/165F Control (ALX1 165L/165L) ALX1 165F/165F
CD57 45.6 ± 7.7% 57.4 ± 7.3% 6.78 ± 2.36% 49.55 ± 17.53%
CD90 55.05 ± 5.24% 63.6 ± 6.9% 88.46 ± 2.05% 67.8 ± 11.07%
CD105 51.7 ± 7.8% 47.6 ± 11.4% 96.31 ± 0.95% 60.02 ± 12.66%
CD73 97.4 ± 1.08% 79.2 ± 9.6% 98.8 ± 0.44% 83.95 ± 6.05%